Pain
News from the FDA/CDC
Arthritis joint pain, inactivity vary greatly across U.S.
The Southeast has the highest rates of adults with severe joint pain and physical inactivity, the CDC reports.
News
What do patients want in a migraine preventive?
Patients with migraine may be willing to trade off efficacy for better adverse event profiles.
From the Journals
Only 1.5% of individuals at high risk of opioid overdose receive naloxone
“Clinicians can address this gap by regularly prescribing naloxone to eligible patients.”
Conference Coverage
Outpatient program successfully tackles substance use and chronic pain
MILWAUKEE – Pain and substance use issues are frequently comorbid in the military health population.
Conference Coverage
Medical cannabis relieved pain, decreased opioid use in elderly
Medical cannabis was an effective and well-tolerated treatment in an elderly cohort of patients with chronic pain.
News from the FDA/CDC
CDC warns against misuse of opioid-prescribing guideline
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....
Conference Coverage
In chronic pain, catastrophizing contributes to disrupted brain circuitry
MILWAUKEE – Brief cognitive-behavioral therapy holds promise to restore functional connectivity disrupted by pain and catastrophizing.
Conference Coverage
In pain treatment, racial bias common among physician trainees
MILWAUKEE – Most residents and fellows who demonstrated racial bias did not report that race factored into treatment decisions.
News
Alvogen issues recall for mislabeled fentanyl patches
The recall was issued because a small number of cartons labeled as containing 12 mcg/h patches contained 50 mcg/h patches.
Conference Coverage
What is medical marijuana actually useful for?
PHILADELPHIA – In a field plagued by “squishy” data, standouts include neuropathic pain, nausea, spasticity, and...
Conference Coverage
No clear winner for treating neuropathic pain
PHILADELPHIA – More head-to-head trials of treatments for neuropathic pain are needed.